There are 5 lines of evidence indicating that the cysteinyl leukotrienes may be involved in the asthmatic response: 1) they are produced by constitutive (mast cells/macrophages) and infiltrating (eosinophils) cells implicated in the asthmatic response, 2) they are potent bronchoconstrictors, 3) asthma is somewhat ameliorated by agents capable of interfering with their synthesis or action, 4) LTC4 is metabolized in humans into LTD4 and LTE4, allowing LTE4 (which can be recovered in the urine) to serve as a marker for all three and 5) the formation of the cysteinyl leukotrienes may not only trigger bronchospasm, but LTE4 may also sensitize the airways to the effects of irritants and/or mediators, leading to bronchial hyperreactivity. Based on these data we tender the following hypothesis: Leukotriene E4 (LTE4), the biometabolic product derived from LTC4 and LTD4, is produced during asthmatic responses. The LTE4 so produced can cause both airway narrowing and hyperresponsiveness. Since a fraction of the LTE4 produced is excreted in the urine, the quantitative urinary excretion of LTE4 provides a possible chemical index of pulmonary obstruction and responsiveness which may be of diagnostic and therapeutic value. This hypothesis will be tested in two specific aims. In this first specific aim, urinary LTE4 excretion will be measured before and after induction of airway hyperresponsiveness by exposure to platelet activating factor (PAF) or ozone in normal subjects. If the transient induction of a hyperresponsive state is associated with the endogenous production of LTE4, then we expect the amounts of LTE4 in the urine to increase in relation to altered airway responsiveness. Three experiments, all in asthmatic subjects, are proposed in the second specific aim. First the relationship between urinary LTE4 excretion and airway responsiveness will be compared in asthmatic subjects with minimal and marked airway responsiveness. Second, the relationship between urinary LTE4 excretion and spontaneous alterations in airway responsiveness that occur during allergen season will be investigated in a group of asthmatic subjects with a documented allergic diathesis. Third the relationship between urinary LTE4 excretion and the variations in airway function that occur during treatment as an acute asthmatic attack resolves will be determined in a group of acutely ill patients.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Ohta, Shin; Imamura, Mitsuru; Xing, Wei et al. (2013) Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation. J Immunol 190:5927-38
Giannattasio, Giorgio; Ohta, Shin; Boyce, Joshua R et al. (2011) The purinergic G protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation. J Immunol 187:1486-95
Lundequist, Anders; Boyce, Joshua A (2011) LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1? release. PLoS One 6:e18192
Saino, Hiromichi; Ukita, Yoko; Ago, Hideo et al. (2011) The catalytic architecture of leukotriene C4 synthase with two arginine residues. J Biol Chem 286:16392-401
Laidlaw, Tanya M; Steinke, John W; Tinana, Adrienne M et al. (2011) Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcýýRI. J Allergy Clin Immunol 127:815-22.e1-5
Giannattasio, Giorgio; Fujioka, Daisuke; Xing, Wei et al. (2010) Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function. J Immunol 185:4430-8
Lundequist, Anders; Nallamshetty, Samridhi N; Xing, Wei et al. (2010) Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation. J Immunol 184:433-41
Jones, Tatiana G; Hallgren, Jenny; Humbles, Alison et al. (2009) Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol 183:5251-60
Jiang, Yongfeng; Borrelli, Laura; Bacskai, Brian J et al. (2009) P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells. J Immunol 182:1129-37
Shin, Kichul; Nigrovic, Peter A; Crish, James et al. (2009) Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 182:647-56

Showing the most recent 10 out of 14 publications